Crown Marketing Inc. (OTCQB: CWNM) is pleased to announce that it has formed a wholly owned subsidiary, a Colorado corporation, known as "Joint Venture Solutions, Inc." ("JVS" or "Company").
The Company's objectives will be two fold. Firstly, it hopes to provide ancillary services such as financing and other "back room" support to companies in the field of medical marijuana, an industry which remains largely shunned by main stream business support professionals. These possibilities are being evaluated on a case-by-case basis.
Secondly, JVS intends to employ most or all of the free cash flow generated from support services to research the benefits of Crown's novel patented controlled delivery device with respect to cannabinoids and more specifically to Cannabidiol, or CBDs.
CBDs are present in almost all strains of the cannabis plant. CBDs are believed to possess many of the therapeutic qualities of THC, but without the psychotropic effects (no "high"). For these reasons, CBDs are considered highly marketable to the segment of the population interested in marijuana related products for the medical benefits but who shy away from the alteration of mood and perception associated with consumption of THC. Because CBDs lack the psychoactive compounds banned under various legal frameworks, CBDs may be marketed nationwide. Moreover, preliminary research indicates that precision time release of CBDs available with Crown's controlled drug delivery technology would not only render consumption more convenient, but would also dramatically improve the pharmacological profile of these compounds, thereby yielding greater medical benefits.